Lexeo Therapeutics, Inc. · NASDAQ:LXEO
Bhalla Narinder Pal received 2,714 Lexeo Therapeutics, Inc. shares as an award (Form 4)
Traded Sep 14, 2026 · Filed Sep 28, 2026
On Sep 14, 2026, Bhalla Narinder Pal (Chief Medical Officer) received 2,714 Lexeo Therapeutics, Inc. shares as an award at US$3.58 for US$9,716, leaving 84,908 shares. Filed Sep 28, 2026 (Form 4).
- Awarded
- 2,714 shares
- Price
- US$3.58
- Value
- US$9,716
- Holding after
- 84,908 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Common Stock | Award | 2,714 | US$3.58 | 84,908 | Direct |
Source
Related
- Lexeo Therapeutics, Inc.
- Bhalla Narinder Pal
- Lexeo Therapeutics, Inc. shareholders
- Form 4 · Bhalla Narinder Pal · Jul 1, 2026
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Otero Jose Manuel · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Sep 28, 2026
- Form 4 · Tamayo Louis Edward · Aug 19, 2026
- Form 4 · Townsend Richard Nolan · Aug 19, 2026